NASDAQ:MREO   Mereo BioPharma Group plc
a clinical-stage company focused on developing & commercialising oncology & rare diseases treatments.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.